REVVITY INC (RVTY) Stock News

Forecasting The Future: 7 Analyst Projections For Revvity

What's going on in today's session: S&P500 movers

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday.

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.

What's going on in today's session: S&P500 movers

Let's delve into the developments on the US markets in the middle of the day on Monday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

How To YieldBoost Revvity To 12.8% Using Options

Revvity to Present at J.P. Morgan Healthcare Conference

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

RVTY Crosses Below Key Moving Average Level

These Analysts Revise Their Forecasts On Revvity Following Q3 Results

Revvity Announces Financial Results for the Third Quarter of 2024

Revvity Board Declares Quarterly Dividend

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report

Revvity To Hold Earnings Call on Monday, November 4, 2024

Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene

Revvity to Present at Upcoming Investor Conferences

RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q2 2024

RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Revvity Announces Financial Results for the Second Quarter of 2024

Revvity Board Declares Quarterly Dividend

Revvity To Hold Earnings Call on Monday, July 29, 2024

Revvity to Present at Goldman Sachs Global Healthcare Conference